Latest information on everolimus manufacturers and prices

Everolimus (Everolimus), as an important targeted therapy drug, plays a key role in the field of cancer treatment. Currently, there are various manufacturers of everolimus, and prices vary depending on factors such as region, brand, and specification. This article will introduce you to the latest information on the major manufacturers and prices of everolimus in the Chinese and Indian markets.

1. Main manufacturers and prices of everolimus in the Chinese market

The manufacturer of everolimus sold in the Chinese market is Novartis Pharmaceuticals of Switzerland. The company's everolimus tablets (trade name: Afinitor/Afinitor) have won wide recognition for their excellent efficacy and safety. Currently, a box of 5mg*30 tablets of Afinitor sells for about several thousand yuan. Specific prices vary depending on regions, hospitals or pharmacies and other sales channels.

2. Major manufacturers and prices of everolimus in the Indian market

In the Indian market, the production of generic drugs of everolimus is also active. Among them, everolimus (trade name: ROLIMUS) produced by Cipla has attracted much attention. This generic drug has obvious advantages in price. A box of ROLIMUS with a specification of 5mg*10 tablets is priced at about 800 to 900 yuan. In addition, Cipla Pharmaceuticals has also launched generic versions of everolimus in other specifications to meet the needs of different patients.

In summary, everolimus, as an important targeted therapy drug, plays a key role in the field of cancer treatment. With the continuous advancement of medical technology and changes in market demand, the manufacturers and prices of everolimus are constantly updated. When using everolimus, patients should choose the appropriate brand and specification based on their own conditions and doctor's recommendations, and pay attention to price dynamics to make an economically reasonable choice.